rs2867125 — TMEM18 TMEM18 regulatory variant (2p25.3)

Regulatory variant at the TMEM18 locus on chromosome 2p25.3 — one of the most replicated obesity GWAS signals — modulating hypothalamic appetite suppression via the paraventricular nucleus

See your personal result for TMEM18

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Hypothalamic Appetite Brake: TMEM18's Role in Weight Control

The chromosome 2p25.3 region, home to TMEM18 (Transmembrane Protein 18), harbors one of the most robustly replicated obesity loci in human genetics. rs2867125 is a regulatory variant that sits within this locus, influencing how the brain's central appetite-regulation hub — the hypothalamic paraventricular nucleus (PVN)11 hypothalamic paraventricular nucleus (PVN)
A cluster of neurons that integrates hunger, satiety, and energy expenditure signals; the brain's primary command centre for body-weight homeostasis — calibrates food intake. Unlike variants that affect metabolism or fat storage, TMEM18 variants act upstream, changing how often and how strongly the brain fires the "stop eating" signal.

The C allele at rs2867125 is the most common allele globally (~85%), meaning most people carry at least one copy of the version associated with reduced appetite suppression. This makes rs2867125 a population-level contributor to obesity: its modest per-allele effect (approximately 0.31 kg/m² BMI) multiplied across billions of C-allele carriers adds up to a meaningful population-wide shift toward higher average body weight.

The Mechanism

TMEM18 encodes a four-transmembrane-domain protein that resides at the nuclear membrane, where it physically interacts with components of the nuclear pore complex22 nuclear pore complex
The gated channel through which molecules move between the nucleus and cytoplasm; TMEM18's interaction here may regulate which genes are expressed in response to feeding signals. Its expression in the PVN responds to nutritional state and is regulated by leptin33 leptin
The satiety hormone secreted by adipose tissue that signals the hypothalamus to reduce appetite; TMEM18 expression in the PVN is modulated by leptin pathway activity. When TMEM18 levels in the PVN are higher, food intake falls and energy expenditure rises; when they are lower, the opposite occurs.

The C allele at rs2867125 reduces TMEM18-mediated expression in this regulatory region, resulting in less PVN appetite suppression. The functional consequence of this gene-expression reduction has been directly demonstrated in mice: germline loss of TMEM18 causes increased body weight driven by hyperphagia (excess food consumption), especially on high-fat diets. Selective overexpression of TMEM18 in the PVN reverses this — reducing food intake and increasing energy expenditure simultaneously. The genotype's effect is dose-dependent: CT heterozygotes have intermediate appetite regulation, with CC homozygotes showing the least hypothalamic restraint.

The Evidence

The [GIANT consortium (Willer et al. 2009) | Meta-analysis of 15 GWAS involving

32,000 individuals with replication in 59,000 more; identified TMEM18 as one of six new BMI loci at genome-wide significance](https://pubmed.ncbi.nlm.nih.gov/19079261/44 https://pubmed.ncbi.nlm.nih.gov/19079261/) first placed the TMEM18 locus among the most reproducible obesity risk regions in the human genome. The Speliotes et al. 2010 meta-analysis55 Speliotes et al. 2010 meta-analysis
GIANT consortium analysis of 249,796 individuals; confirmed TMEM18 among 18 loci with BMI association at p < 5×10⁻⁸; quantified per-allele effect at ~0.31 kg/m² extended these findings to nearly 250,000 individuals, establishing the per-allele BMI effect size of approximately 0.31 kg/m².

The GWAS Catalog documents rs2867125-C associations with BMI at p = 1×10⁻⁷² in the largest available analysis, and with waist circumference at p = 1×10⁻⁴³, confirming effects on both overall adiposity and central fat distribution. A meta-analysis of 27 studies totalling 177,367 individuals66 meta-analysis of 27 studies totalling 177,367 individuals
Li et al. 2021; primary analysis on rs6548238 but including rs2867125 and other TMEM18 variants; OR 1.25 overall, OR 1.28 in children, OR 1.32 in Europeans demonstrated the association with clinically defined obesity.

Cross-ethnic replication adds credibility: the C-allele effect on BMI holds in the same direction in Korean populations, and a pediatric study of 7,225 children found rs2867125 contributed to a genotype risk score in which each additional obesity risk allele raised BMI z-score by 0.09 units — with stronger effects at the upper tail of the BMI distribution, meaning the variant disproportionately pushes individuals toward frank obesity rather than merely nudging average weight.

Practical Implications

Because the C allele is so prevalent (~85% globally), carrying CC is the default for most of humanity, not an unusual condition. The variant's relevance comes from understanding why appetite suppression feels harder for CC carriers: the hypothalamic PVN is less active at restraining food intake. Practical strategies focus on compensating for weaker internal satiety signals using protein-first meal sequencing, pre-portioning, and structured meal timing — approaches that engage peripheral satiety pathways (PYY, GLP-1, CCK) that do not depend on TMEM18 activity.

The association with waist circumference suggests visceral fat accumulation is part of the phenotype, making central adiposity monitoring valuable beyond tracking overall BMI.

Interactions

rs2867125 lies in the TMEM18 regulatory region on chromosome 2p25.3 and is in partial linkage disequilibrium with rs6548238, the primary TMEM18 GWAS tag SNP; both variants contribute to the same biological mechanism but tag partially overlapping sets of haplotypes. Their combined effect should not be double-counted — they represent two windows into the same regulatory locus. Independently, TMEM18 acts additively with the major obesity loci FTO (rs9939609) and MC4R (rs17782313); carrying risk alleles at all three loci compounds the appetite-drive burden without synergistic gene-gene interaction having been demonstrated.

Genotype Interpretations

What each possible genotype means for this variant.

TT Full Appetite Brake Normal

Two protective T alleles — strongest hypothalamic appetite suppression from TMEM18; lowest obesity risk at this locus

You carry two copies of the T allele at rs2867125, found in only about 2% of the global population. This is the most protective genotype at this TMEM18 regulatory locus. Carriers of two T alleles have the highest TMEM18-mediated appetite suppression in the hypothalamic paraventricular nucleus, contributing to stronger endogenous satiety signalling and a lower genetic predisposition to obesity from this locus.

Because the C allele is so prevalent (~85%), the TT genotype represents a naturally uncommon level of appetite regulation. Your BMI advantage from this locus is approximately 0.62 kg/m² less than the common CC genotype (two protective alleles at 0.31 kg/m² each).

CT Intermediate Appetite Brake Intermediate

One C allele — intermediate hypothalamic appetite suppression; moderately elevated obesity risk

TMEM18 expression in the hypothalamic PVN is nutritionally regulated and responds to leptin. C-allele carriers have reduced TMEM18 activity at this locus compared to TT individuals. In the additive model confirmed across GWAS, CT heterozygotes show intermediate BMI compared to CC and TT. The waist circumference association — observed at p = 1×10⁻⁴³ for the C allele — suggests that even one copy predisposes to some degree of central fat redistribution beyond what is explained by BMI alone.

CC Reduced Appetite Brake High Risk

Two C alleles — lowest hypothalamic appetite suppression from TMEM18; highest obesity risk from this locus

TMEM18 in the hypothalamic PVN acts as an energy-balance regulator: higher TMEM18 activity reduces food intake and increases energy expenditure simultaneously. The C allele at rs2867125 reduces TMEM18-mediated expression, lowering the PVN's natural appetite restraint. Functional experiments in mice directly demonstrated this: TMEM18 knockout animals develop diet-induced obesity through hyperphagia, while PVN-specific overexpression reduces both food intake and body fat. The CC genotype translates these mouse findings into a human context — a lifelong, modest reduction in the hypothalamic signal that tells you to stop eating.

Beyond BMI, rs2867125-C is associated with increased waist circumference at p = 1×10⁻⁴³ in GWAS analyses, indicating a particular predisposition to central/visceral adiposity rather than general fat gain alone. The association with type 2 diabetes risk, seen in some cohorts, is likely secondary to the adiposity effect rather than a direct metabolic impairment.